Go to content

European Society for ME - Research & Knowledge

  • ESME
  • Contact
  • Search
  • Translation
  • Home
  • XMRV/MLV Seminar Oslo
  • Danish Conference
  • Recent UPDATES
  • ESME
  • News
  • ME - Facts and Figures
  • Treatment
  • Testing
  • Kids
  • Resources/Guidelines
  • Public Conferences
  • Media
  • Donate
  • Comments
  • XMRV
  • ME Organisations
  • FORUM

You are here:

  • Home

Mission of European Society for ME

Our mission is to create a Think Tank where top scientists from relevant fields can discuss current ME knowledge in order to determine the most crucial direction of future research, and to provide a reliable source of cutting-edge ME information that ESME will incorporate in the education of medical professionals.

Share on      

 

  • New Criteria for ME: Important Tool for Researchers/Clinicians

    ESME recommend that: Researchers use the ICC exclusively and call the disease ME in all written documents about their research. Government agencies/foundations give research grants to scientists using the ICC. Government agencies/institutions officially adopt the ICC and post them on official websites. Doctors use the ICC to diagnose patients and write only ME G93.3 in patient journals or in all written documents about these patients. Advocates/patient associations speak with one voice by agreeing to call the disease ME.

    • Read more
  • Is there a need for an European Parents FORUM for kids with ME/Fibro/Autism/ADHD?

    Is there a need for an European Forum for (ME) parents with kids with ME/Fibromyalgia/autism/ADHD?

    • Read more
  • Announcement: Prof. Dr. Luc Montagnier joins ESME as Honorary Member

    The European Society for ME (ESME) is pleased to announce that Prof. Dr. Luc Montagnier is an honorary member of our organization. He has been an honorary member since May 2nd, 2010 and was also patron of ESME’s launch meeting in Norway (June 2009).

    • Read more
  • Scientific Panel

    An overview of the panel members in the ESME Think Tank .

    • Read more
  • DONATE

    Please help ESME achieve its goals of educating doctors and helping scientists to solve the puzzle of ME.

    • Read more
  • ESME Think Tank Panel: Call to Ban ME- blood Donations in Europe

    The Canadian, Australian and British governments have all banned ME patients from donating blood. We, the Think Tank panel of ESME, applaud their actions and believe that a similar ban should be issued in all European countries. ME patients should be banned from donating blood.

    • Read more
  • Our sponsors

    These sponsors have made ESME a reality!

    • Read more
  • Experts Launch Think Tank for Mystery Disease

    Ten leading scientists in Europe have formed a Think Tank for ME and will hold their first meeting on the 13th of June. They want to initiate an effective research effort to find the secret behind the mystery disease that cripples an increasing number of lives.

    • Read more
  • Our ESME Flyer

    ESME can help you quickly and efficiently spread information about ME/CFS through our extensive database. Ordering flyers is possible.

    • Read more
  • Statement from ESME - European Society for ME

    More Biomedical Research Needed. ESME will encourage research leading to the accumulation of new knowledge and to a better understanding of the disease, and will endeavour to raise funding for biomedical research in, and education about, ME.

    • Read more
1 | 2 Next »
Showing from 1 to 10 of total 13 articles

  

News

  • 27.01.2012 Persbericht: Petitie ME-patiënten: Erken ME als invaliderende biomedische ziekte
  • 08.11.2011 Flyer of the Dutch Petition for recognizing ME as a biological disease
  • 02.11.2011 Dutch Politicial Petition for recognizing ME as Biomedical disease
  • 24.10.2011 All information about the breakthrough of Rutiximab as possible treatment for ME patients from the Norwegian Dr.Mella and Dr. Fluge
  • 20.10.2011 Norwegian research breakthrough can solve CFS-mystery
  • News archive

ESME.com is designed, developed and hosted by Norsk Kunde & Medlemsutvikling